Hepatic Veno-occlusive Disease

• EMA approval · 2023-12-20
  EMA Authorised: Defitelio (defibrotide) — Gentium S.r.l.

  Defitelio (defibrotide) has been authorised by the EMA for hepatic veno-occlusive disease, with Gentium S.r.l. as the marketing authorizatio…

• FDA approval · 2016-03-30
  FDA Approved: DEFITELIO — Original Application (Jazz Pharmaceuticals, Inc.)

  The FDA approved Defibrotide (Defitelio) as the original application for the treatment of hepatic veno-occlusive disease in adults and child…